CCL Products (India) Limited
Financial trend (75/100) does the heavy lifting; valuation (7/100) is the drag.
ExpensiveOvervaluedOur blended model reads CCL Products (India) Limited as a Sell at 39/100. We put fair value near ₹746.87; at ₹1,044.4 that leaves roughly 28% downside, so the stock screens overvalued by 28%. On 40.1x trailing earnings it sits pricier than the Consumer Defensive median of about 26.1x. The price is about 15% below its 52-week high of ₹1,226.28 and 27% above the low of ₹824.72. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 8/9. The average analyst target of ₹1,279.82 implies about 23% upside across 11 analysts. It clears 7 of 14 investability checks, with durability 54, valuation 11 and momentum 29 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹597.49.
Analyst views
1-year price
EOD · 2026-09-2552-week range
-14.83% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell39Piotroski F-score 8/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 18.0%
- Fail: Low debt (D/E < 0.5): 0.56x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 46%
- Pass: Earnings growing: 12%
- Fail: Net margin ≥ 10%: 8.7%
- Fail: Current ratio > 1.5: 1.49
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- Pass: Positive 1-year return
- Pass: Altman Z in safe zone: Z 6.44
- Pass: Piotroski ≥ 7: 8/9
Quarterly results
Annual financials
Shareholding
- Promoter49.2%
- Institutions26.1%
- Public & other24.7%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (18.0%).
- Financially solid — Altman Z 6.44.
- High Piotroski quality score (8/9).
Opportunities
- Revenue growing (46% YoY).
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Rich valuation versus sector peers.
- Trades ~28% above our estimated fair value.
About CCL Products (India) Limited
CCL Products manufactures and sells instant coffee and coffee-related products in India under the Continental brand, including filter coffee, premix coffee, instant coffee, flavored coffee, spray dried coffee powder, agglomerated coffee, freeze dried coffee, freeze concentrated liquid coffee, roast and ground coffee, and roasted coffee beans. The company also exports its products.
CCL Products (India) Limited — frequently asked questions
Is CCL Products (India) Limited a buy, hold or sell?
StocksWizard currently rates CCL Products (India) Limited (CCL) a Sell, based on a blended score of 39/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is CCL Products (India) Limited's fair value?
Our blended DCF and relative-valuation model estimates CCL Products (India) Limited's fair value at about ₹746.87, versus a current price of ₹1,044.4 — roughly 28% downside. On that basis the stock looks overvalued by 28%.
Is CCL Products (India) Limited financially healthy?
CCL Products (India) Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 8/9.
How has CCL Products (India) Limited's share price performed?
CCL Products (India) Limited is up 17% over the past year and down 11% over three months, and last traded at ₹1,044.4. Past performance doesn't predict future returns.
More in Consumer Defensive
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.